Logo
KIDNEY CANCER DRUGS MARKET ANALYSIS
  2. / Market Insights
  3. Kidney Cancer Drugs Market Analysis
all report title image

KIDNEY CANCER DRUGS MARKET ANALYSIS

Kidney Cancer Drugs Market, By Therapy: Targeted Therapy, Immunotherapy, and Chemotherapy, By Pharmacological Class: Angiogenesis Inhibitors, mTOR Inhibitors, Cytokines, and Others (Immune checkpoint inhibitors, CTLA-4 inhibitors, antimetabolites and others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies , and Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

  • Published In : Jun 2024
  • Code : CMI2399
  • Pages :173
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Kidney cancer drugs Market Key Factors

Close-monitor your Competitor's Move, Get Instant Access to the Report

Key Players Insights
  • Pfizer Inc.
  • Novartis AG
  • Bristol-Myers Squibb Company
  • Roche Holding AG (Genentech, Inc.)
  • Bayer AG
  • Exelixis, Inc.
  • Merck & Co., Inc.
  • Eisai Co., Ltd.
  • Aveo Pharmaceuticals
  • AstraZeneca PLC
  • Ipsen Biopharmaceuticals, Inc.
  • GlaxoSmithKline plc
  • Abbott Laboratories Source
  • Amgen Inc.
  • Calithera Biosciences, Inc.
  • Active Biotech
  • Immatics Biotechnologies GmbH
  • Karyopharm Therapeutics

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Press Release

Kidney Cancer Drugs Market to Surpass US$ 10.31 Bn by 2031
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.